|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 |
| (11) | Number of the document | 2401265 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10705728.3 |
| Date of filing the European patent application | 2010-02-22 | |
| (97) | Date of publication of the European application | 2012-01-04 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/024853 |
| Date | 2010-02-22 |
| (87) | Number | WO 2010/099054 |
| Date | 2010-09-02 |
| (30) | Number | Date | Country code |
| 208648 P | 2009-02-26 | US |
| (72) |
KIM, Ronald, M., US
PARMEE, Emma, R., US
SINZ, Christopher Joseph, US
ZIOUZINA, Olga, A., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | DERIVATIVES OF 1-PYRI(MID)IN-2-YL-PYRAZOLE-4-CARBOXYLIC ACID WHICH ARE USEFUL FOR THERAPY OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES |
| DERIVATIVES OF 1-PYRI(MID)IN-2-YL-PYRAZOLE-4-CARBOXYLIC ACID WHICH ARE USEFUL FOR THERAPY OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES |